Dr Ruchi Gupta attended the AAAAI/WAO conference in San Diego, where she explored key updates in anaphylaxis, angioedema, and chronic spontaneous urticaria (CSU). A major highlight was the ...
Dr Gupta attended the 2025 AAAAI/WAO meeting in San Diego, highlighting new insights into anaphylaxis, angioedema, and urticaria. A key highlight was the consensus statement refining the ...
Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch ...
Medpage Today on MSN13d
Seasonal Allergies on the Rise?Among racial and ethnic groups, non-Hispanic white adults reported the highest rate of seasonal allergies (28.4%), followed ...
Medpage Today on MSN13d
Rare Food Allergy Syndrome Increasingly Due to Early Egg, Peanut Introduction?SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...
Asthma & Immunology annual meeting (AAAAI 2025). LP-003 demonstrated superior improvement compared to Omalizumab in mean change of UAS7 (urticaria activity score 7) from baseline and percentage ...
Additionally, preliminary results from Stage 3 of the OUtMATCH study provide early data on introducing allergenic foods into a patient's diet after stopping Xolair. These findings were featured as ...
Location: Convention Center, Ground Level, Hall A.
an antibody therapy targeting c-Kit to treat mast cell-driven diseases like chronic spontaneous urticaria (CSU) and asthma, at the AAAAI 2025 Annual Meeting in San Diego. The new data, from a ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored phase III OUtMATCH study, which provide further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback